LPX-TIIBD

N/A

Report date: 2023/07/17 11:34:25
NME

Base Information

Drug NameLPX-TIIBD
Drug Alias NameLPX-TIIBD
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLAPIX Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLAPIX Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A